AUTHOR=Watson Anna M. D. , Gould Eleanor A. M. , Moody Sarah C. , Sivakumaran Priyadharshini , Sourris Karly C. , Chow Bryna S. M. , Koïtka-Weber Audrey , Allen Terri J. , Jandeleit-Dahm Karin A. M. , Cooper Mark E. , Calkin Anna C. TITLE=Disparate Effects of Diabetes and Hyperlipidemia on Experimental Kidney Disease JOURNAL=Frontiers in Physiology VOLUME=11 YEAR=2020 URL=https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2020.00518 DOI=10.3389/fphys.2020.00518 ISSN=1664-042X ABSTRACT=
It is well established that diabetes is the major cause of chronic kidney disease worldwide. Both hyperglycemia, and more recently, advanced glycation endproducts, have been shown to play critical roles in the development of kidney disease. Moreover, the renin-angiotensin system along with growth factors and cytokines have also been shown to contribute to the onset and progression of diabetic kidney disease; however, the role of lipids in this context is poorly characterized. The current study aimed to compare the effect of 20 weeks of streptozotocin-induced diabetes or western diet feeding on kidney disease in two different mouse strains, C57BL/6 mice and hyperlipidemic apolipoprotein (apo) E knockout (KO) mice. Mice were fed a chow diet (control), a western diet (21% fat, 0.15% cholesterol) or were induced with streptozotocin-diabetes (55 mg/kg/day for 5 days) then fed a chow diet and followed for 20 weeks. The induction of diabetes was associated with a 3-fold elevation in glycated hemoglobin and an increase in kidney to body weight ratio regardless of strain (